{"DataElement":{"publicId":"7552074","version":"1","preferredName":"Neurofibromatosis Type 1 Atypical Feature Type","preferredDefinition":"Text term that represents the kind of atypical feature found in Neurofibromatosis Type 1.","longName":"NF1_ATYP_FTR_TP","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"7552062","version":"1","preferredName":"Neurofibromatosis Type 1 Atypical Feature","preferredDefinition":"The most common type of neurofibromatosis.  It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface.  They can vary markedly in size and color.  The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath tumors, called neurofibromas.  They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures.  Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17._Varying from the norm; not conformable to the type._A prominent or identifiable aspect, region, or site of interest.","longName":"5365631v1.0:7552060v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"5365631","version":"1","preferredName":"Neurofibromatosis Type 1","preferredDefinition":"The most common type of neurofibromatosis.  It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface.  They can vary markedly in size and color.  The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath tumors, called neurofibromas.  They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures.  Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17.","longName":"C3273","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neurofibromatosis Type 1","conceptCode":"C3273","definition":"The most common type of neurofibromatosis.  It is characterized clinically by cutaneous and subcutaneous tumors with patches of hyperpigmentation. The hyperpigmented skin areas, are present from birth and found anywhere on the body surface.  They can vary markedly in size and color.  The dark brown areas are called cafe-au-lait spots. The multiple cutaneous and subcutaneous tumors are nerve sheath tumors, called neurofibromas.  They can develop anywhere along the peripheral nerve fibers. Neurofibromas can become quite large, causing a major disfigurement, eroding bone, and compressing various peripheral nerve structures.  Type 1 neurofibromatosis has dominant inheritance, with a gene locus on the proximal long arm of chromosome 17.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"38B40D2F-78A6-63CB-E050-BB89AD432A5A","latestVersionIndicator":"Yes","beginDate":"2016-07-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2016-07-28","modifiedBy":"ONEDATA","dateModified":"2016-07-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7552060","version":"1","preferredName":"Atypical Feature","preferredDefinition":"Varying from the norm; not conformable to the type.:A prominent or identifiable aspect, region, or site of interest.","longName":"C25428:C73619","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Atypical","conceptCode":"C25428","definition":"Varying from the norm; not conformable to the type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Feature","conceptCode":"C73619","definition":"A prominent or identifiable aspect, region, or site of interest.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96A4505-CECE-027D-E053-4EBD850A015C","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"ONEDATA","dateModified":"2021-01-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96A4505-CEDF-027D-E053-4EBD850A015C","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-21","changeDescription":"Created for NCI-INC0551952 - Curation for 21C0011 1/19/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"7552063","version":"1","preferredName":"Neurofibroma Atypical Feature Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"NF1_ATYP_FTR_TP","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Necrosis","valueDescription":"Necrotic Process","ValueMeaning":{"publicId":"4395393","version":"1","preferredName":"Necrotic Process","longName":"4395393","preferredDefinition":"A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Necrotic Process","conceptCode":"C16897","definition":"A cell death process that is morphologically characterized by a gain in cell volume (oncosis), swelling of organelles, plasma membrane rupture and subsequent loss of intracellular contents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FEB6B12D-7E7B-54C8-E040-BB89AD433F90","latestVersionIndicator":"Yes","beginDate":"2014-07-21","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-07-21","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B96A9BE6-D0C1-3628-E053-4EBD850A3659","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"ONEDATA","dateModified":"2021-01-21","deletedIndicator":"No"},{"value":"Not Applicable","valueDescription":"Not Applicable","ValueMeaning":{"publicId":"5682946","version":"1","preferredName":"Not Applicable","longName":"5682946v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"498B0E12-9B2B-79DC-E053-F662850A0B75","latestVersionIndicator":"Yes","beginDate":"2017-02-27","endDate":null,"createdBy":"ALEYR","dateCreated":"2017-02-27","modifiedBy":"MMADDINENI","dateModified":"2024-02-20","changeDescription":null,"administrativeNotes":"2023.8.15 Alt VM added per ticket request CADSR0002731. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B96A9BE6-D0A3-3628-E053-4EBD850A3659","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"ONEDATA","dateModified":"2021-01-21","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2559666","version":"1","preferredName":"Other","longName":"2559666","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B61F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"LISU","dateModified":"2023-08-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B96A9BE6-D0AD-3628-E053-4EBD850A3659","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"ONEDATA","dateModified":"2021-01-21","deletedIndicator":"No"},{"value":"Mitotic Index â‰¥ 10/10 HPF","valueDescription":"Mitotic Index Greater than or Equal to 10/10 per High Power Field","ValueMeaning":{"publicId":"7552064","version":"1","preferredName":"Mitotic Index Greater than or Equal to 10/10 per High Power Field","longName":"7552064","preferredDefinition":"A microscopic finding indicating the presence of at least ten mitotic figures per ten high power fields in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Greater than or Equal to 10 Mitoses per 10 HPF","conceptCode":"C177115","definition":"A microscopic finding indicating the presence of at least ten mitotic figures per ten high power fields in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96A9BE6-D0CC-3628-E053-4EBD850A3659","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B96A9BE6-D0E5-3628-E053-4EBD850A3659","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"ONEDATA","dateModified":"2021-01-21","deletedIndicator":"No"},{"value":"Mitotic Index 3-9/10 HPF","valueDescription":"Mitotic Index 3 to 9/10 per High Power Field","ValueMeaning":{"publicId":"7552065","version":"1","preferredName":"Mitotic Index 3 to 9/10 per High Power Field","longName":"7552065","preferredDefinition":"A microscopic finding indicating the presence of at least three and at most nine mitotic figures per ten high power fields in a sample. ","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Between 3 and 9 Mitoses per 10 HPF","conceptCode":"C177114","definition":"A microscopic finding indicating the presence of at least three and at most nine mitotic figures per ten high power fields in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96A9BE6-D0EF-3628-E053-4EBD850A3659","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B96A9BE6-D108-3628-E053-4EBD850A3659","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"ONEDATA","dateModified":"2021-01-21","deletedIndicator":"No"},{"value":"Mitotic Index >1/50 HPF and <3/10 HPF","valueDescription":"Mitotic Index Greater than 1/50 and Less than 3/10 per High Power Field","ValueMeaning":{"publicId":"7552066","version":"1","preferredName":"Mitotic Index Greater than 1/50 and Less than 3/10 per High Power Field","longName":"7552066","preferredDefinition":"A microscopic finding indicating the presence of more than one mitotic figure per fifty high power fields and less than three mitotic figures per ten high power fields in a sample.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"More than 1 Mitosis per 50 HPF and Less than 3 Mitoses per 10 HPF","conceptCode":"C177113","definition":"A microscopic finding indicating the presence of more than one mitotic figure per fifty high power fields and less than three mitotic figures per ten high power fields in a sample.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96A9BE6-D112-3628-E053-4EBD850A3659","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B96A9BE6-D12B-3628-E053-4EBD850A3659","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"ONEDATA","dateModified":"2021-01-21","deletedIndicator":"No"},{"value":"Hypercellularity","valueDescription":"Hypercellularity","ValueMeaning":{"publicId":"7552067","version":"1","preferredName":"Hypercellularity","longName":"7552067","preferredDefinition":"An increase in the number of cells in an organ or tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hypercellularity","conceptCode":"C177116","definition":"An increase in the number of cells in an organ or tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96A9BE6-D135-3628-E053-4EBD850A3659","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B96A9BE6-D14E-3628-E053-4EBD850A3659","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"ONEDATA","dateModified":"2021-01-21","deletedIndicator":"No"},{"value":"Loss of neurofibroma architecture","valueDescription":"Loss of neurofibroma architecture","ValueMeaning":{"publicId":"7552068","version":"1","preferredName":"Loss of neurofibroma architecture","longName":"7552068","preferredDefinition":"A gradual decline in amount or activity.: The characteristic shape or pattern of neoplastic cells seen in a neurofibroma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Loss","conceptCode":"C25559","definition":"A gradual decline in amount or activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neurofibroma Architecture","conceptCode":"C177117","definition":"The characteristic shape or pattern of neoplastic cells seen in a neurofibroma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96A9BE6-D158-3628-E053-4EBD850A3659","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B96A9BE6-D171-3628-E053-4EBD850A3659","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"ONEDATA","dateModified":"2021-01-21","deletedIndicator":"No"},{"value":"Cytologic atypia","valueDescription":"Cytologic Atypia","ValueMeaning":{"publicId":"7552070","version":"1","preferredName":"Cytologic Atypia","longName":"7552070","preferredDefinition":"The presence of irregularly shaped or sized cells as compared to the cells that are normally present.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytologic Atypia","conceptCode":"C8326","definition":"The presence of irregularly shaped or sized cells as compared to the cells that are normally present.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96A9BE6-D17E-3628-E053-4EBD850A3659","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B96A9BE6-D197-3628-E053-4EBD850A3659","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"ONEDATA","dateModified":"2021-01-21","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96A9BE6-D08D-3628-E053-4EBD850A3659","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-26","changeDescription":"Created for NCI-INC0551952 - Curation for 21C0011 1/19/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Atypical Features (if applica","type":"Preferred Question Text","description":"Atypical Features (if applicable)","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B96AABCF-F8D7-4F3A-E053-4EBD850A4096","latestVersionIndicator":"Yes","beginDate":"2021-01-21","endDate":null,"createdBy":"COOPERM","dateCreated":"2021-01-21","modifiedBy":"COOPERM","dateModified":"2021-01-21","changeDescription":"Created for NCI-INC0551952 - Curation for 21C0011 1/19/21 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}